Investors use valuation multiples as a gauge to determine the value of a stock. Investors closely track these multiples to make entry and exit decisions on stocks.

Let’s look at how Aurora Cannabis’s (ACB) valuation compares to its peers’.

How Aurora Cannabis’s Valuations Compare to Its Peers’

Aurora versus peers

In the chart above, we’ve compared Aurora Cannabis’s EV-to-EBITDA (enterprise value-to-EBITDA) to those of its peers Canopy Growth (WEED), Tilray (TLRY), and Aphria (APHA). Aurora Cannabis’s most recent valuation multiple is trading at a discount to its peers (HMMJ) Canopy Growth and Tilray.

On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x, Aurora Cannabis was trading at a multiple of 34.2x, and Tilray was trading at a multiple of ~700x. On the other hand, Aphria (APHA) was trading at a discount of 12x to the peer median of 17.7x on the day.

The above valuation multiple takes into account a company’s current EV over its forward EBITDA estimate. Increased leverage makes a stock risky, so it demands a higher return, which will eventually lead to a lower valuation multiple, indicating that investors are pricing in the risk of leverage through higher returns.

For more updates, visit Market Realist’s Healthcare page.

Latest articles

On September 14, drones attacked Saudi Arabia Aramco's oil-infrastructure. Saudi Arabia's oil production has fallen by 50%.

Apple Arcade (AAPL) is a subscription gaming service that was unveiled at Apple’s annual event last week. The service will launch on September 19.

Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

Google has agreed to make a one-time settlement of over $945 million euros to the French ministry. The ministry accused Google of evading taxes.

In Q4 2018, legendary investor George Soros sold all his holding in Apple (AAPL). In Q3 2018, Apple represented around 0.2% of his total portfolio.

Jim Chanos, the founder and president of Kynikos Associates, is a long-time short-seller of Tesla stock. Tesla stock has fallen 17.5% in the last year.